IXHL · Incannex Healthcare Inc. · Insider Trading

$3.26 +0.01 (+0.31%) At close · Sep 11

Market Cap

$39.00M

11.96M

Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.

Query insider transactions through the insider trading API or MCP →

Date	Insider	Role	Type	Security	Shares	Price	Value	After
2025-11-14	Widdows Peter	Director	Award↑ Filing footnotes — Common Stock, $0.0001 par value per share (Direct) Includes the following shares of restricted stock (the "Shares") granted on November 14, 2025, under the Issuer's 2023 Equity Incentive Plan, (i) 421,739 Shares that vest in full on December 10, 2025, (ii) 421,739 Shares that vest in full on June 30, 2026, (iii) 421,739 Shares that vest in full on June 30, 2026 and (iv) 421,739 Shares that vest in full on June 30, 2027.	Common Stock, $0.0001 par value per share	1,686,956	—	—	65,260
2025-11-14	Latham Joel	Director, CEO and President	Award↑ Filing footnotes — Common Stock, $0.0001 par value per share (Direct) Includes the following shares of restricted stock (the "Shares") granted on November 14, 2025, under the Issuer's 2023 Equity Incentive Plan, (i) 5,652,173 Shares that vest in full on December 10, 2025, (ii) 5,652,173 Shares that vest in full on June 30, 2026, (iii) 5,652,173 Shares that vest in full on June 30, 2026 and (iv) 5,652,173 Shares that vest in full on June 30, 2027.	Common Stock, $0.0001 par value per share	22,608,692	—	—	806,206
2025-11-14	Anastassov George	Director	Award↑ Filing footnotes — Common Stock, $0.0001 par value per share (Direct) Includes the following shares of restricted stock (the "Shares") granted on November 14, 2025, under the Issuer's 2023 Equity Incentive Plan, (i) 421,739 Shares that vest in full on December 10, 2025, (ii) 421,739 Shares that vest in full on June 30, 2026, (iii) 421,739 Shares that vest in full on June 30, 2026 and (iv) 421,739 Shares that vest in full on June 30, 2027.	Common Stock, $0.0001 par value per share	1,686,956	—	—	81,889
2025-11-14	Swan Joseph	CFO, Treasurer and Secretary	Award↑ Filing footnotes — Common Stock, $0.0001 par value per share (Direct) Includes the following shares of restricted stock (the "Shares") granted on November 14, 2025, under the Issuer's 2023 Equity Incentive Plan, (i) 289,855 Shares that vest on December 10, 2025, (ii) 289,855 Shares that vest on June 30, 2026; and (iii) 289,855 Shares that vest on June 30, 2027.	Common Stock, $0.0001 par value per share	869,565	—	—	30,712
2025-11-14	Valentine Troy	Director	Award↑ Filing footnotes — Common Stock, $0.0001 par value per share (Direct) Includes the following shares of restricted stock (the "Shares") granted on November 14, 2025, under the Issuer's 2023 Equity Incentive Plan, (i) 2,825,652 Shares that vest in full on December 10, 2025, (ii) 2,825,652 Shares that vest in full on June 30, 2026, (iii) 2,825,652 Shares that vest in full on June 30, 2026 and (iv) 2,825,652 Shares that vest in full on June 30, 2027.	Common Stock, $0.0001 par value per share	11,302,608	—	—	400,062
2025-11-14	Clark Robert	Director	Award↑ Filing footnotes — Common Stock, $0.0001 par value per share (Direct) Includes the following shares of restricted stock (the "Shares") granted on November 14, 2025, under the Issuer's 2023 Equity Incentive Plan, (i) 421,739 Shares that vest in full on December 10, 2025, (ii) 421,739 Shares that vest in full on June 30, 2026, (iii) 421,739 Shares that vest in full on June 30, 2026 and (iv) 421,739 Shares that vest in full on June 30, 2027.	Common Stock, $0.0001 par value per share	1,686,956	—	—	59,565
2024-10-23	Barbato Luigi M.	Chief Medical Officer	Award↑ Filing footnotes — Common Stock (Direct) Restricted stock units. The shares subject to the restricted stock units vest over a period of three years, with 1/3rd of such shares vesting 12 months after October 21, 2024 and at the end of every twelve-month period thereafter over the remaining 24 months, subject to continued service for the Issuer on each vesting date.	Common Stock	100,476	—	—	3,349
2024-05-06	Swan Joseph	CFO, Treasurer and Secretary	Award↑ Filing footnotes — Restricted Shares of Common Stock (Direct) Award of restricted shares of which 16,931 restricted shares vested on June 30, 2024, 16,931 restricted shares will vest on June 30, 2025, and 16,931 restricted shares will vest on June 30, 2026, provided the Reporting Person is still employed on each vesting date. This Form 5 reports the award of 50,793 restricted shares by the Reporting Person pursuant to the Company's Equity Incentive Plan occurred on May 6, 2024.	Restricted Shares of Common Stock	50,793	—	—	1,726
2023-12-21	Latham Joel	Director, CEO and President	Award↑ Filing footnotes — Common Stock (Direct) Award of restricted stock of which 335,000 shares will vest on December 31, 2023, 335,000 shares concerning the remuneration of fiscal year 2023 will vest on June 30, 2024, 335,000 shares concerning the remuneration of fiscal year 2024 will vest on June 30, 2024, and 335,000 shares will vest on June 30, 2025, based upon the Reporting Person's continuing employment on each vesting date.	Common Stock	1,340,000	—	—	52,583
2023-12-21	Valentine Troy	Director	Award↑ Filing footnotes — Common Stock (Direct) Award of restricted stock of which 167,500 shares will vest on December 31, 2023, 167,500 shares concerning the remuneration of fiscal year 2023 will vest on June 30, 2024, 167,500 shares concerning the remuneration of fiscal year 2024 will vest on June 30, 2024, and 167,500 shares will vest on June 30, 2025, based upon the Reporting Person's continuing service as director on each vesting date.	Common Stock	670,000	—	—	23,308
2023-12-21	Anastassov George	Director	Award↑ Filing footnotes — Common Stock (Direct) Award of restricted stock of which 25,000 shares will vest on December 31, 2023, 25,000 shares concerning the remuneration of fiscal year 2023 will vest on June 30, 2024, 25,000 shares concerning the remuneration of fiscal year 2024 will vest on June 30, 2024, and 25,000 shares will vest on June 30, 2025, based upon the Reporting Person's continuing service as director on each vesting date.	Common Stock	100,000	—	—	25,657
2023-12-21	Widdows Peter	Director	Award↑ Filing footnotes — Common Stock (Direct) Award of restricted stock of which 25,000 shares will vest on December 31, 2023, 25,000 shares concerning the remuneration of fiscal year 2023 will vest on June 30, 2024, 25,000 shares concerning the remuneration of fiscal year 2024 will vest on June 30, 2024, and 25,000 shares will vest on June 30, 2025, based upon the Reporting Person's continuing service as director on each vesting date.	Common Stock	100,000	—	—	9,028
2023-12-21	Clark Robert	Director	Award↑ Filing footnotes — Common Stock (Direct) Award of restricted stock of which 25,000 shares will vest on December 31, 2023, 25,000 shares concerning the remuneration of fiscal year 2023 will vest on June 30, 2024, 25,000 shares concerning the remuneration of fiscal year 2024 will vest on June 30, 2024, and 25,000 shares will vest on June 30, 2025, based upon the Reporting Person's continuing service as director on each vesting date.	Common Stock	100,000	—	—	3,333

Legend Buy — open-market purchase Sell — open-market sale ↑ Shares acquired ↓ Shares disposed (gift, conversion, tax…)

Showing 1–13 of 13 transactions

Key facts CIK 1873875 CUSIP 45333F208 13F (30d) 9 filings 9 filers Visit website Investor relations